Skip to main content
Sweden
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Aidian – Your aid in diagnostics
  • Produkter
  • Om oss
  • Nyheter
  • Instrument service
  • Antimikrobiell resistens
  • Aidian Academy
  • Mässor & utställningar
  • Våra kunder berättar
Kontakt Sök
Logo
Kontakt
  • Patientnära diagnostik
  • Mikrobiologi
  • Molekylär mikrobiologi
  • Hygienkontroll
  • RIA / Kollagener
  • Luftvägsinfektioner
  • Andra
Patientnära diagnostik
  • QuikRead go-systemet
  • QuikRead 101
  • Nova Biomedical
  • SD BIOSENSOR STANDARD F
  • bioLytical Laboratories INSTI®
  • ACRO™ Biotech
  • microINR
  • Certest
  • Actim
  • Hangzhou AllTest Biotech
Läs mer
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go tillbehör
QuikRead go
Mikrobiologi
  • Uricult
  • Uricult Vet
  • Cultura M
  • Reagena
  • MIKROGEN serologi
  • Meridian Immunoassays
  • Meridian Curian®
Läs mer
Molekylär mikrobiologi
  • Meridian Revogene®
  • Meridian Alethia®
  • MIKROGEN molecular diagnostics
  • SD BIOSENSOR STANDARD M10
Läs mer
Hygienkontroll
  • Easicult
  • Hygicult
  • Clean Card PRO
Läs mer
RIA / Kollagener
  • UniQ RIA
Läs mer
Andra
  • Grifols Promonitor®
Läs mer
  • Aidian i Sverige
  • Styrelse och ledning
  • Hållbarhet
  • Kultur
  • Karriär hos Aidian
  • Nyheter
  • Produktnyheter
  • AMR
  • Möten
  • Stories from customers
  • COVID-19
  • QuikRead go -serviceorder
  • Vanliga frågor och svar
  • Kontaktinformation
  • Om C-reaktivt protein (CRP)
  • CRP och nedre luftvägsinfektioner
  • Material
  • QuikRead go CRP-produkter
  • Spridning av antibiotikaresistenta bakterier
  • Användbara länkar
  • Allmänt
  • Produktinformation
  • Kurser
  • Dokument och material
  • Vanliga frågor
  • Sovhygien: övervakning av renheten hos kuddar och sängkläder
  • Nya instrument ger patienter rätt vård - på plats direkt
Logo
Kontakt Stäng
  • Produkter
    • Patientnära diagnostik
      • QuikRead go-systemet
      • QuikRead 101
      • Nova Biomedical
      • SD BIOSENSOR STANDARD F
      • bioLytical Laboratories INSTI®
      • ACRO™ Biotech
      • microINR
      • Certest
      • Actim
      • Hangzhou AllTest Biotech
    • Mikrobiologi
      • Uricult
      • Uricult Vet
      • Cultura M
      • Reagena
      • MIKROGEN serologi
      • Meridian Immunoassays
      • Meridian Curian®
    • Molekylär mikrobiologi
      • Meridian Revogene®
      • Meridian Alethia®
      • MIKROGEN molecular diagnostics
      • SD BIOSENSOR STANDARD M10
    • Hygienkontroll
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Kollagener
      • UniQ RIA
    • Luftvägsinfektioner
    • Andra
      • Grifols Promonitor®
  • Om oss
    • Aidian i Sverige
    • Styrelse och ledning
    • Hållbarhet
    • Kultur
    • Karriär hos Aidian
  • Nyheter
    • Nyheter
    • Produktnyheter
    • AMR
    • Möten
    • Stories from customers
    • COVID-19
  • Instrument service
    • QuikRead go -serviceorder
    • Vanliga frågor och svar
    • Kontaktinformation
  • Antimikrobiell resistens
    • Om C-reaktivt protein (CRP)
    • CRP och nedre luftvägsinfektioner
    • Material
    • QuikRead go CRP-produkter
    • Spridning av antibiotikaresistenta bakterier
    • Användbara länkar
  • Aidian Academy
    • Allmänt
    • Produktinformation
    • Kurser
    • Dokument och material
    • Vanliga frågor
  • Mässor & utställningar
  • Våra kunder berättar
    • Sovhygien: övervakning av renheten hos kuddar och sängkläder
    • Nya instrument ger patienter rätt vård - på plats direkt
Populära produkter
AllTest hCG snabbtest

AllTest hCG snabbtest

AllTest MONO snabbtest

AllTest MONO snabbtest

Acro Strep A rapid test

Acro Strep A rapid test

Senaste nyheter
Visa alla

Introduktion av QuikRead go Plus Instrument!

20 januari 2025 | Nyheter, Produktnyheter

Increase in influenza and RSV activity in the EU/EEA

14 januari 2025 | Nyheter

Webinar: A Point-of-Care analyzer for DOAC testing

25 november 2024 | Möten

  • Visa alla
  • Inga resultat
  • Loading...
Nyheter

Introduktion av QuikRead go Plus Instrument!

20 januari 2025 | Nyheter, Produktnyheter

Increase in influenza and RSV activity in the EU/EEA

14 januari 2025 | Nyheter

Tillbaka till alla nyheter
24 november 2021
Nyheter,
Produktnyheter,
AMR

Implementation of QuikRead go CRP POC testing in nursing homes benefits the residents and helps to combat antimicrobial resistance

Overprescribing of antibiotics is common in nursing homes

Antibiotic overprescribing in lower respiratory tract infections (LRTIs) is common in nursing homes because patients may have atypical clinical presentations. Also, the lack of diagnostic options make diagnosis often difficult, and differentiation of severe and self-limiting infections is challenging. Nursing home residents may be fragile, and infections have a high risk to have serious outcomes. Therefore, antibiotics are often prescribed just in case to avoid any risk for the residents. Antimicrobial resistance (AMR) is an emerging health threat and rationalizing antibiotic use in all healthcare settings is important to decelerate the development of ARM.

The UPCARE study investigated the effect and implementation of CRP point of care in nursing homes

C-reactive protein (CRP) point of care testing (POCT) has shown to decrease unnecessary antibiotic prescribing in LRTIs in primary care. Nevertheless, the evidence from the nursing home setting has been lacking. The UPCARE study in the Netherlands (Using Point-of-care C-reactive protein to Guide Antibiotic Prescribing for Respiratory Tract Infections in Elderly Nursing Home Residents) used QuikRead go CRP POCT and investigated the effect of CRP POCT for antibiotic prescribing in nursing homes1. The study also conducted a process evaluation about the implementation of CRP POCT in nursing home facilities and assessed the barriers and facilitators for the use of CRP POCT2.

The implementation of CRP POCT in nursing homes decrease unnecessary antibiotic prescribing for lower respiratory tract infections

The UPCARE study demonstrated that CRP POCT decreased antibiotic prescribing for LRTIs by 29 % compared to usual care without increasing the number of hospitalizations, mortality or affecting patient's recovery1. Furthermore, physicians who participated in the study felt that the use of CRP POCT was one of the main factors that changed their antibiotic prescribing behaviour for LRTIs during the study period2. These findings support the idea that large-scale implementation of CRP POCT is useful in nursing homes and aids the management of LRTI’s.

Easy access to the analyzer and good communication between the personnel facilitate successful CRP POC implementation

Adoption of new interventions in nursing homes can be challenging because patients are heterogenic, and the nursing home setting may be complex. To support the use of CRP POCT in a nursing home setting, authors provided key recommendations for CRP implementation in the nursing home setting2:

  • Implementation of CRP POCT is recommended in medium to large nursing homes with >75 residents.
  • Cooperate with a primary care laboratory.
  • Appoint 1-2 team champions per location for medical training (physician) and management of the POCT user group (physician or a nurse).
  • POCT group should be manageable and proportional to the number of residents.
  • POCT analyzer and materials needed for testing should be within a short distance.
  • Short line communication is important between personnel involved with CRP POCT.
  • Exchange of experiences regarding CRP POCT during team meetings.

As seen in the UPCARE study, implementations of new interventions, such as CRP POCT, may provide substantial benefits for nursing home residents.1,2 Reduction of unnecessary antibiotic prescribing decrease the unnecessary medication of the residents and possible adverse events of the antibiotics. Also, rational antibiotic prescribing helps to fight against the global threat of antimicrobial resistance.


References

  1. Boere TM, van Buul LW, Hopstaken RM et al. Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial. BMJ 2021; 374:n2198.
  2. Boere TM, Hopstaken RM, van Tulder MW et al. Implementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes. JAMDA 2021, in press https://doi.org/10.1016/j.jamda.2021.09.010
Share
Facebook
Twitter
E-post

Aidian Sweden AB

Råsta Strand väg 13C
169 79 Solna


08 623 04 00


Förfrågningar
info@aidian.se


Försäljning
order@aidian.se

Företag
  • Om oss
  • Hållbarhet
  • Karriär hos Aidian
  • Kontakt
Produkter
  • Patientnära diagnostik
  • Mikrobiologi
  • Molekylär mikrobiologi
  • Hygienkontroll
  • RIA / Kollagener
  • Luftvägsinfektioner
  • Andra
Snabblänkar
  • Aidian Academy
  • Aidian Connect
  • Instrument service
Copyright © 2025 Aidian
  • Integritetsskyddspolicy
  • Integritetsmeddelande
  • Cookiepolicy
  • Sociala medier policy